{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T18:36:49Z","timestamp":1774463809317,"version":"3.50.1"},"reference-count":24,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T00:00:00Z","timestamp":1726704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NIH","award":["R01MH125849"],"award-info":[{"award-number":["R01MH125849"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The gabapentenoids such as gabapentin (GP) and pregabalin are approved for the treatment of chronic pain, but their utility is limited by persistent side effects. These adverse effects result from GPs affecting many types of neurons and muscle cells, not just the pain-sensing neurons that are the intended targets. We have recently discovered a type of peripheral neuron, rat sympathetic neurons from the superior cervical ganglion (SCG), that is uniquely insensitive to GP effects. Currents were measured using whole-cell patch-clamp electrophysiology from cells in primary culture from either the SCG or the Nodose Ganglion (NDG) as a positive control for the effects of GP. We find that the calcium current density was dramatically reduced by GP pretreatment in NDG neurons, but that neurons from the SCG were resistant. Further, when GP was cytoplasmically injected into these neurons, the resistance of SCG neurons to GP treatment persisted. These data demonstrate that rat sympathetic neurons appear to be uniquely resistant to GP treatment. These results may help us to better understand the mechanism of action of, and resistance to, GP in altering calcium channel current density, which may help to develop future treatments with fewer side effects.<\/jats:p>","DOI":"10.3390\/ph17091237","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T04:59:54Z","timestamp":1726721994000},"page":"1237","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rat Sympathetic Neuron Calcium Channels Are Insensitive to Gabapentin"],"prefix":"10.3390","volume":"17","author":[{"given":"Mallory B.","family":"Scott","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8191-2284","authenticated-orcid":false,"given":"Paul J.","family":"Kammermeier","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Shanthanna, H., Gilron, I., Rajarathinam, M., AlAmri, R., Kamath, S., Thabane, L., Devereaux, P.J., and Bhandari, M. (2017). Benefits and safety of gabapentinoids in chronic low back pain: A systematic review and meta-analysis of randomized controlled trials. PLoS Med., 14.","DOI":"10.1371\/journal.pmed.1002369"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4997\/jrcpe.2017.402","article-title":"Gabapentin and pregabalin: Do the benefits outweigh the harms?","volume":"47","author":"Morrison","year":"2017","journal-title":"J. R. Coll. Physicians Edinb."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","article-title":"The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel","volume":"271","author":"Gee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/syn.10094","article-title":"Preferential action of gabapentin and pregabalin at P\/Q-type voltage-sensitive calcium channels: Inhibition of K+-evoked [3H]-norepinephrine release from rat neocortical slices","volume":"45","author":"Dooley","year":"2002","journal-title":"Synapse"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.celrep.2018.02.021","article-title":"The alpha2delta-1-NMDA Receptor Complex Is Critically Involved in Neuropathic Pain Development and Gabapentin Therapeutic Actions","volume":"22","author":"Chen","year":"2018","journal-title":"Cell Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/ALN.0b013e31825153ea","article-title":"Gabapentin inhibits catecholamine release from adrenal chromaffin cells","volume":"116","author":"Todd","year":"2012","journal-title":"Anesthesiology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1023\/A:1024078704020","article-title":"Gabapentin blocks L-type and P\/Q-type Ca2+ channels involved in depolarization-stimulated nitric oxide synthase activity in primary cultures of neurons from mouse cerebral cortex","volume":"20","author":"Oka","year":"2003","journal-title":"Pharm. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0028-3908(01)00181-2","article-title":"Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression","volume":"42","author":"Martin","year":"2002","journal-title":"Neuropharmacology"},{"key":"ref_9","first-page":"727","article-title":"Differential effect of gabapentin on neuronal and muscle calcium currents","volume":"297","author":"Alden","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1083\/jcb.200805048","article-title":"CaMKII locally encodes L-type channel activity to signal to nuclear CREB in excitation-transcription coupling","volume":"183","author":"Wheeler","year":"2008","journal-title":"J. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neures.2011.02.004","article-title":"Excitation-transcription coupling in sympathetic neurons and the molecular mechanism of its initiation","volume":"70","author":"Ma","year":"2011","journal-title":"Neurosci. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"aad2395","DOI":"10.1126\/science.aad2395","article-title":"Structure of the voltage-gated calcium channel Cav1.1 complex","volume":"350","author":"Wu","year":"2015","journal-title":"Science"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrn3311","article-title":"Calcium channel auxiliary alpha2delta and beta subunits: Trafficking and one step beyond","volume":"13","author":"Dolphin","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5369","DOI":"10.1113\/JP272262","article-title":"Voltage-gated calcium channels and their auxiliary subunits: Physiology and pathophysiology and pharmacology","volume":"594","author":"Dolphin","year":"2016","journal-title":"J. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"8979","DOI":"10.1073\/pnas.1403731111","article-title":"Functional exofacially tagged N-type calcium channels elucidate the interaction with auxiliary alpha2delta-1 subunits","volume":"111","author":"Cassidy","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0006-3495(01)75799-2","article-title":"Evidence for two concentration-dependent processes for beta-subunit effects on alpha1B calcium channels","volume":"81","author":"Canti","year":"2001","journal-title":"Biophys. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"52323","DOI":"10.1074\/jbc.M303564200","article-title":"The voltage-dependent calcium channel beta subunit contains two stable interacting domains","volume":"278","author":"Opatowsky","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"33554","DOI":"10.1074\/jbc.M112.378554","article-title":"Calcium currents are enhanced by alpha2delta-1 lacking its membrane anchor","volume":"287","author":"Kadurin","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.1523\/JNEUROSCI.2700-10.2010","article-title":"The alpha2delta ligand gabapentin inhibits the Rab11-dependent recycling of the calcium channel subunit alpha2delta-2","volume":"30","author":"Dolphin","year":"2010","journal-title":"J. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/19336950.2017.1356954","article-title":"CaV2 channel subtype expression in rat sympathetic neurons is selectively regulated by alpha2delta subunits","volume":"11","author":"Scott","year":"2017","journal-title":"Channels"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1073\/pnas.0708930105","article-title":"Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin","volume":"105","author":"Hendrich","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1152\/jn.1986.55.3.527","article-title":"Na+ and Ca2+ currents of acutely isolated adult rat nodose ganglion cells","volume":"55","author":"Ikeda","year":"1986","journal-title":"J. Neurophysiol."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sapio, M.R., Vazquez, F.A., Loydpierson, A.J., Maric, D., Kim, J.J., LaPaglia, D.M., Puhl, H.L., Lu, V.B., Ikeda, S.R., and Mannes, A.J. (2020). Comparative Analysis of Dorsal Root, Nodose and Sympathetic Ganglia for the Development of New Analgesics. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.615362"},{"key":"ref_24","first-page":"e1614","article-title":"Intranuclear microinjection of DNA into dissociated adult mammalian neurons","volume":"10","author":"Lu","year":"2009","journal-title":"J. Vis. Exp."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/9\/1237\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:59:21Z","timestamp":1760111961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/17\/9\/1237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":24,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["ph17091237"],"URL":"https:\/\/doi.org\/10.3390\/ph17091237","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]}}}